During the past decade, Unidad Especializada en Tabaquismo de la Comunidad de Madrid conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad Especializada en Tabaquismo de la Comunidad de Madrid" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Unidad Especializada en Tabaquismo de la Comunidad de Madrid" are "Smoking Cessation" (2 trials). Many other conditions were trialed in "Unidad Especializada en Tabaquismo de la Comunidad de Madrid" in a lesser frequency.

Most popular intervention types in "Unidad Especializada en Tabaquismo de la Comunidad de Madrid" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nicotine Replacement Therapy Patch" (2 trials), "bupropion hydrochloride" (2 trials), "varenicline tartrate" (2 trials), "Placebo" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unidad Especializada en Tabaquismo de la Comunidad de Madrid" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Unidad Especializada en Tabaquismo de la Comunidad de Madrid". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Unidad Especializada en Tabaquismo de la Comunidad de Madrid, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Unidad Especializada en Tabaquismo de la Comunidad de Madrid, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".